CVS is planning a multiyear program aimed at saving $2 billion by leveraging AI, automation, and streamlining operations, according to company presentation materials cited by Bloomberg reported prior to CVS’ scheduled earnings call Aug. 7.
The Woonsocket, R.I.-based company announced the additional belt-tightening measures Aug. 7 alongside its second quarter earnings, which included another downward revision to its annual outlook — the second in 2024. CVS now forecasts annual adjusted earnings of $6.40 to $6.65 per share, down from at least $7 per share. Cash flow from operations is projected to be around $9 billion, a decrease from the previous estimate of at least $10.5 billion.
The company reported total quarterly revenue of $91.2 billion, up 2.6% from a year ago, driven by growth in its Medicare and commercial insurance sectors. However, increased medical costs and utilization offset much of this gain, resulting in adjusted earnings per share of $1.83 — down 17.2% from the year prior. Its adjusted operating income decreased 16.4% year-over-year to $3.7 billion, primarily due to challenges in the Health Care Benefits and Pharmacy & Consumer Wellness segments.
The $2 billion cost-cutting plan follows last year’s initiative to cut up to $800 million in costs, which involved the elimination of 5,000 “non-customer facing positions” and the use of AI.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
